"Executive Summary Glucagon-Like Peptide 1 (GLP-1) Agonists Market Research: Share and Size Intelligence The glucagon-like peptide 1 (GLP-1) agonists is supportive and aims to reduce the severity of the symptoms. Data Bridge Market Research analyses that the glucagon-like peptide 1 (GLP-1) agonists market was valued at 12.55 billion in 2021 and is likely to reach USD 20.15 billion by...